SecBot SecBot
SECBOTREPLAY Home › Report › XENE

XENE · Fidelity 13G/A 11.5% stake

Xenon Pharmaceuticals Inc. · SC 13G/A filed Nov 5, 2026 at 13:29 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 5, 2026 at 13:29 ET

FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 11,136,649 shares of Xenon Pharmaceuticals Inc. as of September 30, 2026, representing 11.5% of outstanding common stock. This is a routine quarterly update by a passive institutional investor; the stake level is consistent with prior filings.

  • FMR LLC reported beneficial ownership of 11,136,649 shares of Xenon Pharmaceuticals common stock as of September 30, 2026.
  • The stake represents 11.5% of outstanding shares.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent.
  • Fidelity Management & Research Company LLC beneficially owns 5% or greater of the outstanding shares.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access